Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

TCRX

TScan Therapeutics (TCRX)

TScan Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TCRX
FechaHoraFuenteTítuloSímboloCompañía
13/05/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
13/05/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
13/05/202406:00GlobeNewswire Inc.TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TCRXTScan Therapeutics Inc
09/05/202406:00GlobeNewswire Inc.TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid TumorsNASDAQ:TCRXTScan Therapeutics Inc
24/04/202415:05GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
24/04/202410:03GlobeNewswire Inc.TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:TCRXTScan Therapeutics Inc
22/04/202416:01GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
19/04/202409:05GlobeNewswire Inc.TScan Therapeutics Announces Closing of Upsized Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202423:30GlobeNewswire Inc.TScan Therapeutics Announces Pricing of Upsized $150 Million Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202415:25GlobeNewswire Inc.TScan Therapeutics Announces Launch of $125 Million Proposed Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202415:01GlobeNewswire Inc.TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term PrioritiesNASDAQ:TCRXTScan Therapeutics Inc
08/04/202407:00GlobeNewswire Inc.TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical OfficerNASDAQ:TCRXTScan Therapeutics Inc
02/04/202406:00GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
06/03/202415:11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TCRXTScan Therapeutics Inc
06/03/202415:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCRXTScan Therapeutics Inc
06/03/202406:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCRXTScan Therapeutics Inc
14/02/202415:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRXTScan Therapeutics Inc
29/08/202307:02Dow Jones NewsTScan Gets FDA Clearance of Investigational New Drug Application for Cancer TreatmentNASDAQ:TCRXTScan Therapeutics Inc
24/07/202318:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
24/07/202318:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
29/06/202307:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRXTScan Therapeutics Inc
15/06/202317:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRXTScan Therapeutics Inc
12/06/202315:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCRXTScan Therapeutics Inc
08/06/202312:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRXTScan Therapeutics Inc
06/06/202309:25Dow Jones NewsTScan Therapeutics Shares Rise 17% After FDA Clears IND for Cancer TreatmentNASDAQ:TCRXTScan Therapeutics Inc
02/06/202315:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCRXTScan Therapeutics Inc
02/06/202315:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TCRXTScan Therapeutics Inc
30/05/202305:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TCRXTScan Therapeutics Inc
26/05/202305:43Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:TCRXTScan Therapeutics Inc
25/05/202318:50Dow Jones NewsStocks to Watch: Marvell Technology, Workday, Gap, TScan TherapeuticsNASDAQ:TCRXTScan Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRX